DUBLIN, Oct. 17,
2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will
host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m.
BST) on Thursday, Oct. 24,
2024 to discuss the company's third quarter financial
results.
The webcast player and accompanying slides may be accessed on
the Investors section of Alkermes' website at www.alkermes.com. The
conference call may be accessed by dialing +1 877 407 2988 for U.S.
callers and +1 201 389 0923 for international callers. A replay of
the webcast will be available approximately two hours after the
completion of the event and may be accessed by visiting Alkermes'
website.
About Alkermes plc
Alkermes plc is a global
biopharmaceutical company that seeks to develop innovative
medicines in the field of neuroscience. The company has a portfolio
of proprietary commercial products for the treatment of alcohol
dependence, opioid dependence, schizophrenia and
bipolar I disorder, and a pipeline of clinical and preclinical
candidates in development for neurological disorders, including
narcolepsy and idiopathic hypersomnia. Headquartered
in Ireland, Alkermes
also has a corporate office and research and development
center in Massachusetts and a
manufacturing facility in Ohio.
For more information, please visit Alkermes' website
at www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-report-third-quarter-financial-results-on-october-24-2024-302279558.html
SOURCE Alkermes plc
